(Circulation. 1998;97:1105.)
© 1998 American Heart Association, Inc.
Images in Cardiovascular Medicine |
Amiodarone Skin Toxicity
Jasbir Sra, MD;
; Siobhan Bremner, BSN, MPH
From the Electrophysiology Laboratory, St Luke's Medical Center,
University of Wisconsin-Milwaukee Clinical Campus.
Correspondence to Jasbir Sra, MD, 2901 W Kinnickinnic River Pkwy 470, Milwaukee, WI 53215-3660.
Bluish-grey discoloration of the face after 1 year
of treatment with amiodarone in a 54-year-old man with a
history of ventricular tachycardia (left).
Discoloration has almost completely disappeared 9 months after the drug
was discontinued (right). The patient was given an implantable
cardioverter-defibrillator for recurrent sustained
ventricular tachycardia.
Footnotes
The editor of Images in Cardiovascular Medicine is Hugh A. McAllister, Jr, MD, Chief, Department of Pathology, St Luke's Episcopal Hospital and Texas Heart Institute, and Clinical Professor of Pathology, University of Texas Medical School and Baylor College of Medicine.
Circulation encourages readers to submit cardiovascular images to Dr Hugh A. McAllister, Jr, St Luke's Episcopal Hospital and Texas Heart Institute, 6720 Bertner Ave, MC1267, Houston, TX 77030.